Lexicon Pharmaceuticals, Inc. (LXRX)

Last Closing Price: 1.42 (2025-12-04)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Lexicon Pharmaceuticals, Inc. (LXRX) had Net Income of $-12.77M for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$14.18M
Net Income
$-12.77M
$0.01M
$14.17M
$26.37M
$-12.19M
$-0.58M
$-12.77M
$-12.77M
$-12.77M
$-12.77M
$-12.77M
$-12.77M
$-12.19M
$-11.63M
363.40M
363.40M
$-0.04
$-0.04
Balance Sheet Financials
$122.53M
$1.98M
$83.40M
$205.93M
$21.72M
$56.51M
$64.05M
$85.77M
$120.16M
$75.62M
$120.16M
363.40M
Cash Flow Statement Financials
$-50.62M
$108.19M
$-45.57M
$66.66M
$78.66M
$12.00M
$9.68M
--
--
Fundamental Metrics & Ratios
5.64
--
--
0.32
0.47
99.93%
-85.93%
-85.93%
--
-90.04%
-90.04%
$-50.62M
--
--
--
0.07
0.06
6.08
14.81
-10.63%
-16.89%
-6.20%
-7.23%
$0.33
$-0.14
$-0.14